Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.
Turnstone Biologics is a privately-held clinical stage biotech company.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
SixPeaks Bio is developing a pipeline of medicines for healthy weight loss.
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Borealis Biosciences is a company in the field of next-generation RNA medicines.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma.
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
A UK-based developer of drugs to treat respiratory diseases
Versant Ventures has invested in 89 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Versant Ventures's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 14 different industry categories.
Among tracked funding rounds, CRISPR Therapeutics received $550.0M in a Post-IPO Debt round. Versant Ventures's total known invested capital is $4.4B.
Versant Ventures's average investment size is $68.2M across its portfolio of 89 companies.
Recent Versant Ventures portfolio additions include Tarveda Therapeutics, Venatorx Pharmaceuticals, AllRock Bio, T-knife, Vector BioPharma. These companies were founded in 2020 or later.